Unveiling Potential of DNA Polymerase III Inhibitors to Limit Helicobacter pylori

webinar

Thu, 28 Jul 2022, 16:00 CEST (Berlin)

Dr. Sumera Zaib, University of Central Punjab (UCP), Pakistan

Unveiling Potential of DNA Polymerase III Inhibitors to Limit Helicobacter pylori

Helicobacter pylori is the most common gram-negative pathogen that causes chronic gastric inflammation and may lead to gastric cancer. To date, it is hard to eradicate and manage H. pylori infections but with limited combination therapies consistent efforts are in process. However, the immense and repetitive use of the same combination therapies over time made the bacterium resistant to several drugs. Consequently, H. pylori has been considered as a serious threat to human health and require novel antimicrobial drug candidates.

Considering the resistance mechanisms of H. pylori, the DNA polymerase III subunit β (DnaN) was selected as the drug target against which several inhibitors were optimized. Some of the inhibitors were found to be highly potent inhibitors of DnaN as evaluated by utilizing built-in libraries of BioSolveIT, infiniSee, CoLibri, FTrees, SeeSAR’s Inspirator and Molecule Editor Mode, and ReCore. We have discovered a benzamide derivatives as lead class of inhibitor for DnaN via AI- based docking, virtual screening, molecular editing, and toxicological investigation.

Looking forward to your active participation.

Current news

category
Software
Molecular Superpositioning with the Similarity Scanner
October 14, 2022 11:02 CEST
Molecular superpositioning of small molecules is one of the pillars of ligand-based drug discovery (LBDD). In LBDD cheminformatics methods are applied to 3D align a molecule set with a query structure based on tool criteria, e.g., motifs, interaction features, and substructures. Subsequently, the 3D alignment can be exploited to investigate...
Read on
Freedom Space by Chemspace — a Source for Accessible Ideation
October 13, 2022 14:11 CEST
The Freedom Space received an update by Chemspace to include the latest available in-stock building blocks. The Chemical Space is based on six validated and robust chemical reactions with high synthesis success rate which can be performed in almost every synthetic lab. The reactions include acylation, reductive amination, arylation, and...
Read on
category
Challenge
Winner of Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash with Covalent Tuberculosis Drugs
September 20, 2022 12:56 CEST
We are excited to announce the winner of the Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash from the Madras Christian College (Chennai, India)! In the past twelve months he used the covalent docking feature of SeeSAR to screen for potential drug candidates to treat tuberculosis infections. He got the best...
Read on